Beyond Air (XAIR) Net Equity Issued and Repurchased (2017 - 2026)
Beyond Air (XAIR) posted Net Equity Issued and Repurchased of $3.8 million for Q1 2026, up 442.86% sequentially from $700000.0 in Q4 2025, and down 79.19% YoY from $18.3 million in Q1 2025.
Beyond Air (XAIR) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
Beyond Air has reported Net Equity Issued and Repurchased for 9 years, with the latest figure at $3.8 million in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 79.19% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 65.87% YoY) and the FY2026 annual result came in at $4.5 million, down 76.14% from the prior year.
- Net Equity Issued and Repurchased improved to $3.8 million in Q1 2026 per XAIR's latest filing, from $700000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $18.3 million in Q1 2025 and troughed at -$18.3 million in Q4 2024.
- A 5-year average of $2.4 million and a median of $3.5 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased sank 2715.42% in 2023, then soared 278.17% in 2024.
- Over 5 years, Net Equity Issued and Repurchased stood at $214000.0 in 2022, then tumbled by 2715.42% to -$5.6 million in 2023, then tumbled by 226.21% to -$18.3 million in 2024, then surged by 103.83% to $700000.0 in 2025, then jumped by 442.86% to $3.8 million in 2026.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $3.8 million, $700000.0, and $18.3 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Beyond Air | 3.61 Mn | -7.30 Mn | 225,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.80 Mn |
| Mar 31, 2026 | 3.80 Mn |
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 18.26 Mn |
| Mar 31, 2025 | 18.26 Mn |
| Dec 31, 2024 | -18.26 Mn |
| Dec 31, 2024 | -18.26 Mn |
| Mar 31, 2024 | 13.18 Mn |
| Mar 31, 2024 | 13.18 Mn |
| Sep 30, 2023 | -5.60 Mn |
| Sep 30, 2023 | -5.60 Mn |
| Jun 30, 2023 | 5.81 Mn |
| Jun 30, 2023 | 5.81 Mn |
| Mar 31, 2023 | 3.49 Mn |
| Mar 31, 2023 | 3.49 Mn |
| Sep 30, 2022 | 214,000.00 |
| Sep 30, 2022 | 214,000.00 |
| Dec 31, 2021 | 10.10 Mn |
| Dec 31, 2021 | 10.10 Mn |